Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Altimmune, Inc. | 59,600 | reported | 07 Jan 2015 | tx 7+510,807−59,200 |
| OSIRIS THERAPEUTICS, INC. | 30,000 | reported | 06 Mar 2018 | tx 2+30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2018 | GRANT_AWARD | OSIRIS THERAPEUTICS, INC. | 10,000 | 0.00 USD | deriv |
| 26 Feb 2018 | GRANT_AWARD | OSIRIS THERAPEUTICS, INC. | 20,000 | 8.92 USD | deriv |
| 07 Jan 2015 | EXERCISE | Altimmune, Inc. | 29,600 | 1.13 USD | |
| 07 Jan 2015 | SALE | Altimmune, Inc. | 29,600 | 2.10 USD | |
| 07 Jan 2015 | EXERCISE | Altimmune, Inc. | 29,600 | 0.00 USD | deriv |
| 08 Dec 2014 | GRANT_AWARD | Altimmune, Inc. | 186,207 | — | deriv |
| 29 Jan 2014 | GRANT_AWARD | Altimmune, Inc. | 210,000 | — | deriv |
| 03 Dec 2012 | GRANT_AWARD | Altimmune, Inc. | 75,000 | — | deriv |
| 16 Nov 2011 | PURCHASE | Altimmune, Inc. | 10,000 | 1.38 USD |